iCAD Overview
- Year Founded
-
1984

- Status
-
Public
- Employees
-
66

- Stock Symbol
-
ICAD

- Investments
-
8
- Share Price
-
$3.72
- (As of Tuesday Closing)
iCAD General Information
Description
icad Inc is a medical technology company providing cancer detection and therapy solutions. The Company operates in one segment: Detection. The Detection segment includes image analysis and workflow solutions that enable healthcare professionals to serve patients by identifying pathologies, comprehensive range of high-performance, Artificial Intelligence and Computer-Aided Detection (CAD) systems and workflow solutions for 2D and 3D mammography, Magnetic Resonance Imaging and Computed Tomography. The company geographically operates in France, Belgium, Italy, Germany, Switzerland and All other.
Contact Information
Website
www.icadmed.comCorporate Office
- 2 Townsend West
- Suite 6
- Nashua, NH 03063
- United States
Corporate Office
- 2 Townsend West
- Suite 6
- Nashua, NH 03063
- United States
iCAD Stock Performance
As of 08-Jul-2025, iCAD’s stock price is $3.72. Its current market cap is $101M with 27.3M shares.
(As of Tuesday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$3.72 | $3.71 | $1.19 - $4.01 | $101M | 27.3M | 811K | -$0.20 |
iCAD Financials Summary
As of 31-Mar-2025, iCAD has a trailing 12-month revenue of $19.5M.
In Thousands, USD |
TTM 31-Mar-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 |
---|---|---|---|---|
EV | 39,146 | 29,850 | 28,112 | 24,965 |
Revenue | 19,528 | 19,608 | 17,318 | 19,802 |
EBITDA | (5,211) | (5,693) | (7,294) | (9,716) |
Net Income | (5,227) | (5,616) | (4,847) | (13,656) |
Total Assets | 39,472 | 37,540 | 41,418 | 51,705 |
Total Debt | 307 | 362 | 461 | 672 |
iCAD Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
iCAD Comparisons
Industry
Financing
Details
iCAD Competitors (23)
One of iCAD’s 23 competitors is Mevion Medical Systems, a Private Equity-Backed company based in Littleton, MA.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Mevion Medical Systems | Private Equity-Backed | Littleton, MA | ||||
Synaptive Medical | Venture Capital-Backed | Toronto, Canada | ||||
ContextVision | Corporation | Stockholm, Sweden | ||||
Kheiron Medical Technologies | Formerly VC-backed | London, United Kingdom | ||||
Sun Nuclear | Formerly PE-Backed | Melbourne, FL |
iCAD Patents
iCAD Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
AU-2019384179-A1 | System and method for assessing breast cancer risk using imagery | Inactive | 23-Nov-2018 | ||
AU-2025204096-A1 | System and method for assessing breast cancer risk using imagery | Pending | 23-Nov-2018 | ||
EP-3884458-A1 | System and method for assessing breast cancer risk using imagery | Pending | 23-Nov-2018 | ||
EP-3884458-A4 | System and method for assessing breast cancer risk using imagery | Pending | 23-Nov-2018 | ||
US-11205265-B2 | System and method for assessing breast cancer risk using imagery | Active | 23-Nov-2018 | G06Q50/163 |
iCAD Signals
iCAD Acquisitions (8)
iCAD’s most recent deal was a Merger/Acquisition with VuCOMP for . The deal was made on 13-Jan-2016.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
VuCOMP | 13-Jan-2016 | Merger/Acquisition | Monitoring Equipment | ||
VuCOMP (Breast Density software) | 29-Apr-2015 | Merger/Acquisition | Decision/Risk Analysis | ||
DermEbx | 15-Jul-2014 | Merger/Acquisition | Therapeutic Devices | ||
Radion | 15-Jul-2014 | Merger/Acquisition | Enterprise Systems (Healthcare) | ||
Xoft | 30-Dec-2010 | Merger/Acquisition | Other Devices and Supplies |
iCAD ESG
Risk Overview
Risk Rating
Updated April, 01, 2022
25.25 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 15,638
Rank
Percentile

Healthcare
Industry
of 636
Rank
Percentile

Health Care IT Services
Subindustry
of 32
Rank
Percentile

iCAD Exits (1)
iCAD’s most recent exit was on 30-Dec-2010 from Xoft. The exit was categorized as .
Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
---|---|---|---|---|---|
Xoft | 30-Dec-2010 | Completed |
|
iCAD Affiliates
Subsidiaries (1)
Name | Industry | Location | Year Founded |
---|---|---|---|
Qualia Computing | Beavercreek, OH | 1997 |
iCAD FAQs
-
When was iCAD founded?
iCAD was founded in 1984.
-
Where is iCAD headquartered?
iCAD is headquartered in Nashua, NH.
-
What is the size of iCAD?
iCAD has 66 total employees.
-
What industry is iCAD in?
iCAD’s primary industry is Diagnostic Equipment.
-
Is iCAD a private or public company?
iCAD is a Public company.
-
What is iCAD’s stock symbol?
The ticker symbol for iCAD is ICAD.
-
What is the current stock price of iCAD?
As of 08-Jul-2025 the stock price of iCAD is $3.72.
-
What is the current market cap of iCAD?
The current market capitalization of iCAD is $101M.
-
What is iCAD’s current revenue?
The trailing twelve month revenue for iCAD is $19.5M.
-
Who are iCAD’s competitors?
Mevion Medical Systems, Synaptive Medical, ContextVision, Kheiron Medical Technologies, and Sun Nuclear are some of the 23 competitors of iCAD.
-
What is iCAD’s annual earnings per share (EPS)?
iCAD’s EPS for 12 months was -$0.20.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »